Search results
Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business. Namita Thapar is passionate about improving women’s health in India and promoting youth entrepreneurship.
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals. She has also been a prominent investor in Shark Tank India investing in over 100 companies. She is also the founder of Thapar Entrepreneur Academy.
16 hours ago · Entrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in Emcure Pharmaceuticals. With the company's IPO launch on July 3, Ms Thapar will sell approximately ...
Namita Thapar will offload a partial stake of about 12.68 lakh shares under the OFS component. Net proceeds from the IPO will be utilised by the company for debt repayment and general corporate ...
Namita Thapar (born 21 March 1977) is an Indian entrepreneur, business executive, and angel investor. She is the Executive director of Emcure Pharmaceuticals . She has also been a prominent investor in Shark Tank India investing in over 100 companies.
Executive Director, India Business. Ms. Namita Thapar joined Emcure as CFO, post her 6-year stint at Guidant Corporation, USA, . Subsequently her responsibilities grew to managing Emcure’s largest business unit, the India Business.
2 days ago · Namita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on Shark Tank, is set to earn approximately Rs 127 crore through the company's upcoming IPO. The issue ...
18 hours ago · Namita Thapar-backed Emcure Pharma IPO opens: GMP, price, apply or not? Emcure Pharmaceuticals initial public offering is set to open for subscription on Wednesday, July, 3, 2024 ... a revenue growth of 11.33 per cent, amounting to Rs 6,715 crore compared to Rs 6,031 crore in FY23. However, the company's profit after tax (PAT) declined by 6.1 per cent to Rs 527 crore in FY24 from Rs 561 crore in FY23. Emcure Pharma IPO share allotment. The company has allocated up to 50 per cent of the ...
15 hours ago · The initial public offering (IPO) of Emcure Pharmaceuticals Limited, which is backed by Namita Thapar, opened for subscription on Wednesday looking to raise Rs 1,952.03 crore. The IPO includes a fresh issue of equity shares worth Rs 800 crore and an offer for sale (OFS) of 1.14 crore equity shares amounting to Rs 1,152 crore at the upper end of ...
21 hours ago · Shark Tank fame Namita Thapar is expected to get 293 times return from her initial investment after partially offloading her stake in Emcure Pharma, as per the company's red herring prospectus. Thapar holds 63.39 lakh shares of Emcure Pharma, which represents a 3.5% stake in the company.
